Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6496
    +0.0007 (+0.11%)
     
  • OIL

    82.69
    -0.67 (-0.80%)
     
  • GOLD

    2,338.40
    -3.70 (-0.16%)
     
  • Bitcoin AUD

    99,789.12
    -2,908.77 (-2.83%)
     
  • CMC Crypto 200

    1,397.29
    -26.81 (-1.88%)
     
  • AUD/EUR

    0.6072
    +0.0015 (+0.25%)
     
  • AUD/NZD

    1.0951
    +0.0020 (+0.19%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,483.95
    +12.47 (+0.07%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,396.01
    -107.68 (-0.28%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

Abiomed's Heart Pump Can Improve Outcomes in Some Patients

Abiomed's Heart Pump Can Improve Outcomes in Some Patients

New trial data supports the use of the company's Impella heart pumps in high-risk patients undergoing surgery to treat their coronary heart disease.